47.05
10 X Genomics Inc (TXG) 最新ニュース
10x Genomics stock hits 52-week high at 46.35 USD - Investing.com UK
How 10x Genomics Inc. (TXG) Affects Rotational Strategy Timing - Stock Traders Daily
Bioinformatics Collaboration and Licensing Deals 2019-2026 | Compare Upfronts, Milestones, and Royalties for 1,230+ Deals - GlobeNewswire Inc.
10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026 - BioSpace
ETFs Investing in 10x Genomics Inc Class A Stocks - TradingView
10x Genomics to report Q2 2026 results on August 6 - scanx.trade
10x Genomics sets Aug. 6 webcast to discuss second-quarter results - Stock Titan
Top 3 Health Care Stocks That May Implode This Month - Benzinga
TXG Stock Rallies As Wall Street Hikes Price Targets - StocksToTrade
10x Genomics Is Maintained at Buy by Canaccord Genuity - Moomoo
4 Best Genetic Sequencing Stocks for 2026 and How to Invest - The Motley Fool
BofA Securities Adjusts 10x Genomics Price Target to $46 From $30 - Moomoo
10x Genomics, Inc. Stock 12‑Month Price Target Raised to $35.46, Implies 17% Downside - TradingView
Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - MSN
10x Genomics Inc. (TXG) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Does 10x Genomics (TXG) Leaving Russell Value Indexes Reframe Its Growth Versus Profitability Story? - Yahoo Finance
TXG Stock Climbs As Wall Street Hikes Price Targets - StocksToTrade
Is 10x Genomics (TXG) Overvalued Following Its Earnings Beat? - Yahoo Finance
10x Genomics stock hits 52-week high at 40.65 USD - Investing.com
10x Genomics stock hits 52-week high at 40.65 USD By Investing.com - Investing.com India
10x Genomics, Inc. Stock 12‑Month Price Target Raised to $32.08, Implies 14% Downside - TradingView
10x Genomics Is Maintained at Equal-Weight by Morgan Stanley - Moomoo
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG) - Yahoo Finance
10x Genomics Is Maintained at Neutral by Citigroup - Moomoo
Price to sales forward of 10x Genomics Inc Class A – SWB:1KJ - TradingView
Enterprise value to revenue forward of 10x Genomics Inc Class A – SWB:1KJ - TradingView
Enterprise value to EBIT forward of 10x Genomics Inc Class A – SWB:1KJ - TradingView
What Does 10x Genomics' (TXG) Russell Value Index Exit Reveal About Its Evolving Investor Base? - simplywall.st
1KJ Forecast — Price Target — Prediction for 2027 - TradingView
Piper Sandler raises 10X Genomics stock price target on clinical pivot - Investing.com UK
10x Genomics stock hits 52-week high at 37.58 USD - Investing.com
10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 3000 Value Benchmark - marketscreener.com
10x Genomics Inc Class A Actuals & Estimates (FWB:1KJ) - TradingView
10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 3000E Value Benchmark - marketscreener.com
10x Genomics Inc Class A Actuals & Estimates (DUS:1KJ) - TradingView
Stocks making big moves this week: Qualcomm, Accenture, 10x Genomics, Seagate, and Lattice Semiconductor - Yahoo Finance
Price to earnings forward of 10x Genomics, Inc. – NASDAQ:TXG - TradingView
10x Genomics Inc Class A Actuals & Estimates (MUN:1KJ) - TradingView
Enterprise value to revenue forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
10x Genomics Inc Class A Actuals & Estimates (NASDAQ:TXG) - TradingView
Enterprise value to EBIT forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
10X Genomics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
10x Genomics Inc Class A Actuals & Estimates (LSE:0A88) - TradingView
Enterprise value to EBITDA forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
10x Genomics Inc Class A Actuals & Estimates (BIVA:TXG) - TradingView
Price to sales forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
TXG Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
10x genomics CEO Serge Saxonov sells $1.03m in stock By Investing.com - Investing.com Australia
Form 4 10X Genomics Inc For: 24 June By Investing.com - Investing.com Australia
10x genomics CEO Serge Saxonov sells $1.03m in stock - Investing.com
10x Genomics Insider Sold Shares Worth $1,033,269, According to a Recent SEC Filing - marketscreener.com
大文字化:
|
ボリューム (24 時間):